latest news releases from the newsroom
PartnerTech Signs Collaboration Agreement with Saab Bofors Dynamics and Acquires Production Unit in Karlskoga
STOCKHOLM, Sweden, Nov. 15, 2002 (PRIMEZONE) -- In accordance with their previous letter of intent, PartnerTech (Stockholm:PART) and Saab Bofors Dynamics have signed an extended collaboration agreement. PartnerTech is also acquiring the Bofors Dynamics machining center in Karlskoga. With some 120 employees, the unit generates annual sales of approximately SEK 150 million. The acquisition and collaboration agreement are expected to boost PartnerTech EPS immediately after the takeover.
Investor AB Allocates SEK 600 Million to RAM Rational Asset Management
STOCKHOLM, Sweden, Nov. 15, 2002 (PRIMEZONE) -- As announced earlier, Investor AB (Other OTC:IVSBF) has decided to allocate capital to RAM Rational Asset Management, an independent asset manager owned by former Investor Executive Vice President Sven Nyman. The amount of capital has been set at SEK 600 million.
Kungsleden Sells and Let
STOCKHOLM, Sweden, Nov. 15, 2002 (PRIMEZONE) -- The property company Kungsleden AB (publ) (Other OTC:KGSDF) (Stockholm:KLED) has sold the property Kopmannen 7 located in Vasteras. The property is a part of the Halla commercial center. The building has been extended during this year and the opening of the new mall is planed to end of November. The sale generated a profit of SEK 35 million.
Vodafone Sverige AB
Vodafone Sverige AB: James Bond on Your Mobile -- In Colour, Pictures and Sound
STOCKHOLM, Sweden, Nov. 15, 2002 (PRIMEZONE) -- On November 28, James Bond will once again be hitting Swedish screens in the 20th James Bond film, "Die Another Day." But for Vodafone Sweden's customers, the Bond experience goes beyond the cinema. Vodafone Sweden's new consumer concept, Vodafone live!, will enable them to access a host of Bond-related material -- such as colour pictures, screen-savers, ring tones and news -- via their mobile phones.
CeNeS Pharmaceuticals Plc
CeNeS Announces Further Positive Results of its Phase II Clinical Trials of Morphine-6-glucuronide (M6G)
CAMBRIDGE, U.K., Nov. 15, 2002 (PRIMEZONE) -- CeNeS Pharmaceuticals plc (LSE:CEN) (Other OTC:CPHAF) today announced additional positive results from its recent Phase II trial comparing the analgesic efficacy of morphine-6-glucuronide (M6G) with morphine. The study showed that patients undergoing hip replacement surgery obtained equivalent post-operative pain relief with M6G as with a standard regime of morphine. The study was carried out under the CeNeS/Elan Corporation, plc (NYSE:ELN) ("Elan") joint venture that was initiated in June 2001. M6G is now ready to enter its Phase III trial programme in Europe subject to regulatory approval.
Intrum Justitia Forms Strategic Alliance with D&B RMS in the Americas and Asia
STOCKHOLM, Sweden, Nov. 15, 2002 (PRIMEZONE) -- Intrum Justitia (Other OTC:INJJF) (Stockholm:IJ), with operations in 21 European countries, and D&B Receivable Management Services (D&B RMS) with offices in the United States, Canada, Mexico and Hong Kong, signed an exclusive multi-year strategic alliance to provide receivables management services for each other's clients on a global scale.